---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-25-000094"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:44:49.989257+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Medtronic appoints Dr. Joon Lee as independent director, effective June 18, 2025

## Summary
- Board increased from 10 to 11 members; Dr. Lee appointed independent director.
- Dr. Lee is CEO of Emory Healthcare, overseeing $7.7B revenue, 12 hospitals, 29,000+ employees.
- He will serve on the Science & Technology and Compensation & Talent Committees.
- Dr. Lee previously held executive roles at UPMC over 25 years, including EVP and President of Physician Services.
- Appointment effective June 18, 2025; standard director compensation applies under existing policy.

## SEC filing metadata
- accession: 0001613103-25-000094
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000094/0001613103-25-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000094/mdt-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-25-000094
- JSON: https://secwatch.observer/filing/0001613103-25-000094.json
- Plain text: https://secwatch.observer/filing/0001613103-25-000094.txt

## Key facts
- Executive change
  Dr. Joon Lee was appointed as Director at Medtronic plc.
  - Action: appointed
  - Role: Director
  source text: On June 18, 2025, the Board of Directors (Board) of Medtronic plc (Company) increased the size of the Board from 10 to 11 and appointed Dr. Joon Lee as a new director of the Company, in each case effective as of June 18, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000094/0001613103-25-000094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.